M H Luzecky, K D Burman, E R Schultz. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Amitriptyline/adverse effectsAmitriptyline/therapeutic useCognition Disorders/drug therapyFatigue/drug therapyFemaleHumansHyponatremia/chemically inducedMiddle AgedOsmolar ConcentrationSodium/bloodSodium/urineSyndromeVasopressins/metabolism
Substances: See more » VasopressinsAmitriptylineSodium
Year: 1974 PMID: 4817485 DOI: 10.1097/00007611-197404000-00027
Source DB: PubMed Journal: South Med J ISSN: 0038-4348 Impact factor: 0.954